Clinical Trials on Plague, Pneumonic in New Zealand

Total 960 results

Akesobio Australia Pty Ltd

Completed

A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects

Coronavirus Disease 2019 (COVID-19)

New Zealand
Jiangsu Rec-Biotechnology Co., Ltd.
Iqvia Pty Ltd

Completed

Safety, Reactogenicity and Immunogenicity Study of ReCOV

Covid19

New Zealand
Valneva Austria GmbH

Completed

VLA2001 Booster in Adult Participants After Priming With mRNA COVID-19 Vaccine and/or Natural SARS-CoV-2 Infection

SARS-CoV-2 Infection

New Zealand, Netherlands
University of New Mexico

Completed

University of New Mexico Dental Hygiene (UNM)

Oral Plaque Biofilm

United States
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque (PREVENT)

Coronary Artery Disease | Plaque, Atherosclerotic

Korea, Republic of, Taiwan, United States, Japan, New Zealand
NeuroActiva, Inc.
Biomed Industries, Inc.

Unknown

A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19 (OPV-NA831)

Covid19 | SARS-CoV-2 | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)

New Zealand, United States
Menzies School of Health Research
University of Malaya; Nanyang Technological University; Griffith University; The... and other collaborators

Active, not recruiting

Hospitalised Pneumonia With Extended Treatment (HOPE) Study (HOPE)

Pneumonia

Australia, Malaysia, New Zealand
Cubist Pharmaceuticals LLC

Terminated

Study of Intravenous Ceftolozane/Tazobactam Compared to Piperacillin/Tazobactam in Ventilator-Associated Pneumonia

Ventilator-Associated Pneumonia (VAP)

United States, Australia, New Zealand
GE Healthcare
Covance; H2O Clinical LLC

Completed

Re-Read Study to Compare the Brain Uptake of [18F]Flutemetamol With Brain Neuritic Plaque Density Determined Postmortem

Cognitive Impairment

United States
DynPort Vaccine Company LLC, A GDIT Company

Completed

Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without Adjuvant

Plague Vaccine

United States
Icahn School of Medicine at Mount Sinai
UCB Pharma; Psoriasis Treatment Center of Central New Jersey

Recruiting

Bimekizumab in Plaque Psoriasis

Plaque Psoriasis

United States
Astellas Pharma Inc
Astellas Pharma Canada, Inc.

Terminated

Assess the Long-term Effectiveness and Safety of Amevive (Alefacept) in Subjects With Moderate to Severe Chronic Plaque Psoriasis (AWARE-2)

Chronic Plaque Psoriasis

Canada
Cadrock Pty. Ltd.
Centre for Digestive Diseases, Australia

Terminated

Anti-chlamydophila Antibiotic Combination Therapy in the Treatment of Patients With Coronary Heart Disease (ACAC-CHD)

Coronary Heart Disease | Chlamydophila Pneumoniae Infections

Australia
Colgate Palmolive

Completed

Clinical Study to Compare Dental Plaque Control

Dental Plaque

United States
Colgate Palmolive

Completed

Investigation of Dental Plaque and Gingival Index

Dental Plaque

United States
Icahn School of Medicine at Mount Sinai

Completed

Ammonium Lactate Lotion 12% (Lac-hydrin®) and Halobetasol Propionate Ointment 0.05% (Ultravate®) in the Treatment and Maintenance of Psoriasis

Plaque Psoriasis

United States
Rockefeller University

Terminated

Cell Responses to IFN-gamma

Plaque Psoriasis

United States
Colgate Palmolive

Completed

Study to Determine the Anti-plaque Efficacy of Commerical Toothpastes and an Oral Rinse

Dental Plaque

United States
Colgate Palmolive

Completed

Clinical Research Study Efficacy of a Prototype Oral Rinse (Quigley)

Dental Plaque

United States
Colgate Palmolive

Completed

Training and Calibration of Dental Examiners

Dental Plaque

United States
Colgate Palmolive

Completed

Evaluating Commercial Anti-Plaque Products and Oral Rinse

Dental Plaque

United States
Aurigene Discovery Technologies Limited

Completed

A Dose-Ranging Phase II Study of AUR101 in Psoriasis (INDUS-3) (INDUS-3)

Plaque Psoriasis

United States
Provectus Pharmaceuticals

Terminated

Topical PH-10 Aqueous Hydrogel and Photodynamic Therapy for Psoriasis

Plaque Psoriasis

United States
UCB Biopharma SRL

Completed

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis (BE RADIANT)

Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque Psoriasis

United States, Australia, Belgium, Canada, France, Germany, Netherlands, Poland, Spain, Turkey, United Kingdom
UCB Biopharma SRL

Recruiting

A Study to Evaluate the Efficacy, Safety, and Drug Concentration of Certolizumab Pegol (CZP) in Children and Adolescent Study Participants With Moderate to Severe Chronic Plaque Psoriasis (PSO) (CIMcare)

Moderate Chronic Plaque Psoriasis | Severe Chronic Plaque Psoriasis | Mixed Guttate/Plaque Psoriasis

United States, Canada, Puerto Rico
Pfizer

Completed

A Study to Investigate the Anti-Plaque Effect of AN0128 Toothpaste

Dental Plaque

United States
Colgate Palmolive

Completed

Compare the Clinical Efficacy of Prototype Toothpastes

Dental Plaque

United States
Taro Pharmaceuticals USA

Completed

Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis

Plaque Psoriasis

United States
Icahn School of Medicine at Mount Sinai
Bausch Health Americas, Inc.

Completed

Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type Psoriasis

Plaque Psoriasis | Palmoplantar Psoriasis

United States
Icahn School of Medicine at Mount Sinai

Completed

Enstilar® Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of Color

Psoriasis | Plaque Psoriasis

United States
Pfizer

Completed

Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age

COVID-19 | SARS-CoV-2 Infection

Australia, New Zealand
Novartis Pharmaceuticals

Completed

Evaluation of the Effectiveness of Secukinumab in Patients With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

United States
Psoriasis Treatment Center of Central New Jersey
Celgene

Completed

Apremilast 30mg Bid With Narrowband UVB in the Treatment of Plaque Psoriasis

Plaque Psoriasis

United States
UCB Biopharma SRL

Completed

A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Moderate to Severe Chronic Plaque Psoriasis (PSO)

Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque Psoriasis

United States, Canada
New York Presbyterian Brooklyn Methodist Hospital

Completed

Serratus Anterior Plane Block Combined With Transversus Thoracic Muscle Plane Block Versus Conventional Local Anesthetic Infiltration for SICD Implantation: A Randomized Controlled Trial

Serratus Anterior Plane Block | Transversus Thoracis Plane Block | Subcutaneous ICD

United States
NeoStrata Company, Inc.

Completed

NB-UVB Phototherapy With and Without Topical LCD Treatment: a Bilateral Pilot Study

Plaque Psoriasis

United States
Rockefeller University
Doris Duke Charitable Foundation

Terminated

Narrowband UVB Phototherapy in the Treatment of Psoriasis Vulgaris

Chronic Plaque Psoriasis

United States
Idera Pharmaceuticals, Inc.

Completed

Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis

Moderate to Severe Plaque Psoriasis | Actively Extending Plaque Psoriasis

United States
BioNTech SE
Pfizer

Completed

Safety and Immunogenicity of BNT162b2 Coadministered With SIIV in Adults 18 Through 64 Years of Age

COVID-19 | SARS-CoV-2 Infection

Australia, New Zealand
Hangzhou Highlightll Pharmaceutical Co., Ltd

Recruiting

The Efficacy and Safety of TLL018 in Moderate-to-severe Plaque Psoriasis

Plaque Psoriasis

United States
Primus Pharmaceuticals
Prosoft Clinical

Terminated

DFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis

Plaque Psoriasis

United States
Arcutis Biotherapeutics, Inc.

Completed

Twin Trial of PDE4 Inhibition With Roflumilast for the Management of Plaque Psoriasis (DERMIS-2)

Chronic Plaque Psoriasis

United States, Canada
Stiefel, a GSK Company
GlaxoSmithKline

Withdrawn

Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis

Plaque Psoriasis

United States
University of New Mexico

Completed

Ixekizumab in Adult Patients With Lichen Planus and Lichen Planopilaris

Lichen Planus | Lichen Planopilaris | Lichen Planus Scalp

United States
Bausch Health Americas, Inc.
Dow Pharmaceutical Sciences

Completed

Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis

Plaque Psoriasis

United States
Taro Pharmaceuticals USA

Completed

Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis

Plaque Psoriasis

United States
Taro Pharmaceuticals USA

Completed

An Open Label, Safety Study to Assess the Potential for Adrenal Suppression

Plaque Psoriasis

United States
Taro Pharmaceuticals USA

Completed

Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Plaque Psoriasis

Plaque Psoriasis

United States
Colgate Palmolive

Completed

Clinical Study to Evaluate Dental Plaque

Gingival Diseases

United States
Bayer

Terminated

Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP) (RISE-IIP)

Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary

Belgium, Israel, Spain, United States, Switzerland, New Zealand, Greece, Portugal, Japan, Argentina, Canada, Denmark, France, Germany, Russian Federation, Turkey, Colombia, Saudi Arabia, Australia, Italy, United Kingdom

Clinical Trials on Plague, Pneumonic in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations